Key result
This feature highlights specific adverse drug reactions to promote awareness, prevention, and reporting to the FDA's MEDWATCH program.
This feature highlights specific adverse drug reactions to promote awareness and reporting to the FDA's MEDWATCH program.
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's MEDWATCH program (800-FDA-1088). If you have reported an interesting preventable ADR to MEDWATCH, please consider sharing the account with our readers. In 2004, ISMP is celebrating the 10th anniversary of its incorporation as a nonprofit organization. The Institute represents more than 20 years of experience in helping health care practitioners keep patients safe, and continues to lead efforts to improve the medication use process.
No takes yet. Share an insight, caveat, or question.
Joel Shuster (2004) conducted an editorial in Adverse drug reactions. This feature highlights specific adverse drug reactions to promote awareness, prevention, and reporting to the FDA's MEDWATCH program.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: